Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TEKMIRA PHARM
(NQ:
TKMR
)
4.800
USD
+0.100 (+2.13%)
Streaming Delayed Price
/ Updated:
1:38 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
15,759
Open
4.750
Bid (Size)
4.720 (100)
Ask (Size)
4.790 (300)
Prev. Close
4.700
Today's Range
4.681 - 4.800
52wk Range
1.770 - 6.780
Shares Outstanding
14,376,715
Dividend Yield
N/A
Top News
More News
Tekmira Announces Election of Directors
May 17, 2013
from
GlobeNewswire News Releases
Tekmira Presents LNP Technology Innovations at Scientific Symposium
May 15, 2013
Highlights Include Advancements in LNP Potency, Lyophilization, and Subcutaneous Administration
Read More
from
GlobeNewswire News Releases
More News
Read More
Tekmira Provides Corporate Update and Announces First Quarter 2013 Results
May 14, 2013
from
GlobeNewswire News Releases
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results
May 09, 2013
from
GlobeNewswire News Releases
Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program
May 08, 2013
from
GlobeNewswire News Releases
Early-Stage Clinical Data Highlights from AACR 2013
April 16, 2013
category
DMPI
,
ARQL
,
TKMR
, and 2 more.
from
Bio-Wire.Com
Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR)
April 10, 2013
from
GlobeNewswire News Releases
Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting
April 09, 2013
from
GlobeNewswire News Releases
Zacks Analyst Grant Zeng: 6 Biotechs with Staggering Potential
April 04, 2013
category
PBIO
,
NEO
,
TKMR
, and 4 more.
from
Bio-Wire.Com
Promising RNA Company Tekmira Ready To Release Data At AACR 2013
April 02, 2013
category
Long Ideas
,
TKMR
,
Brian L/ Wilson
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.